Sponsor pipeline

Arvinas Inc. clinical trial pipeline

Get alerts when Arvinas Inc.'s trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Phase 1
1
Phase 1/2
2

Active trials

NCT IDTitleConditionStatusUpdated
Phase 1/2
NCT07749586 A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced… Advanced Solid Tumor Recruiting 2026-10-13
NCT07023731 A Study to Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D Mutation KRAS G12D Mutation Active, Not Recruiting 2026-09-16
Phase 1
NCT06393738 A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma. Relapsed/Refractory (R/R) Mature B Cell Non Hodgkin Lymphoma (NHL) Recruiting 2026-09-04

Disease areas by active trials, top 10 of 19

Colorectal Cancer (2) · Gastric Cancer (2) · Head & Neck Cancer (2) · Lung Cancer (2) · Melanoma (2) · Non-Small Cell Lung Cancer (NSCLC) (2) · Ovarian Cancer (2) · Breast Cancer (1) · Cervical Cancer (1) · Cholangiocarcinoma (1)

Get alerts when Arvinas Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free